ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Dr Agarwal'S Eye Hospital's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹650 Mil.
Dr Agarwal'S Eye Hospital's average Total Assets over the quarter that ended in Mar. 2026 was ₹7,665 Mil. Therefore, Dr Agarwal'S Eye Hospital's annualized ROA % for the quarter that ended in Mar. 2026 was 8.48%.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's ROA % or its related term are showing as below:
BOM:526783'
s ROA % Range Over the Past 10 Years
Min: -0.97 Med: 10.22 Max: 13.16
Current: 9.97
During the past 13 years, Dr Agarwal'S Eye Hospital's highest ROA % was 13.16%. The lowest was -0.97%. And the median was 10.22%.
BOM:526783's ROA % is ranked better than 86.53% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.77
vs BOM:526783: 9.97
Dr Agarwal'S Eye Hospital (BOM:526783) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's ROA % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Dr Agarwal'S Eye Hospital (BOM:526783) has a ROA % of 8.48% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is 17% below median its historical median of 10.22. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #92 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 13.5%.
Is Dr Agarwal'S Eye Hospital's ROA % too high?
Dr Agarwal'S Eye Hospital's current ROA % of 8.48% is 17% below median its 10-year median of 10.22. The Healthcare Providers & Services industry median ROA % is 1.77. Dr Agarwal'S Eye Hospital's value of 8.48% is 379.1% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #92 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #92 out of 683 companies for ROA %. This places Dr Agarwal'S Eye Hospital in the top 14% of its industry — outperforming the majority of peers. The industry median ROA % is 1.77. Dr Agarwal'S Eye Hospital's value of 8.48% is 379.1% above this benchmark. While the company's 10-year median is 10.22 vs. the industry median of 1.77, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.77, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current ROA % of 8.48% is 379.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current ROA % is 8.48%, which is 17% below median its own 10-year median of 10.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,310.81, compared to a current price of ₹5,041.05 — trading 5.1% below its estimated fair value. The current ROA % is 8.48%, which is 17% below median its 10-year median of 10.22 and 379.1% above the Healthcare Providers & Services industry median of 1.77. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current ROA % is 8.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,041.05 is trading 5.1% below its estimated GF Value™ of ₹5,310.81.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
ROA %: 8.48% (17% below median its 10-year median of 10.22)
GF Value™: ₹5,310.81 vs. price of ₹5,041.05 (5.1% below fair value)
Industry Position: 379.1% above the Healthcare Providers & Services median (#92 of 683)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score
Get the complete analysis for BOM:526783
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
